Valuation: DexCom, Inc.

Market Cap 27.49B 24.03B 22.09B 20.59B 39.05B 2,618B 39.64B 265B 103B 1,287B 103B 101B 4,434B P/E 2026 *
29.1x
P/E 2027 * 24.4x
Enterprise Value 27.09B 23.68B 21.76B 20.29B 38.48B 2,579B 39.06B 261B 102B 1,268B 102B 99.5B 4,369B EV / Sales 2026 *
5.18x
EV / Sales 2027 * 4.51x
Free-Float
93.34%
Yield 2026 *
-
Yield 2027 * -
1 day-0.32%
1 week+2.64%
Current month+5.07%
1 month-0.32%
3 months+15.61%
6 months+9.62%
Current year+9.08%
1 week 58.6
Extreme 58.6
62.4
1 month 58.6
Extreme 58.6
67.8
Current year 48.5
Extreme 48.5
67.8
1 year 46.88
Extreme 46.88
77.17
3 years 46.88
Extreme 46.88
131.88
5 years 46.88
Extreme 46.88
144.55
10 years 9.12
Extreme 9.125
144.55
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
-0.32%+2.64% - - 27.49B
+3.49%+1.36%-29.04%-11.02% 166B
+5.04%+2.73%-5.88%-4.53% 106B
+2.80%+3.63%+0.09%+55.31% 57.69B
+1.33%+1.39%+53.16%+49.84% 53.2B
+3.39%+1.39%-10.26%-39.65% 43.56B
+3.50%+11.11% - - 36.52B
+0.20%+4.24%+64.56%-3.33% 25.84B
+2.78%+1.17%-8.15%-0.43% 21.27B
+1.96%+2.08%-8.43%-1.27% 20.3B
Average +2.42%+3.98%+7.01%+5.61% 59B
Weighted average by Cap. +3.08%+3.35%-3.52%+3.40%

Financials

2026 *2027 *
Net sales 5.22B 4.57B 4.2B 3.91B 7.42B 497B 7.53B 50.39B 19.59B 245B 19.61B 19.19B 843B 5.83B 5.1B 4.68B 4.37B 8.28B 555B 8.41B 56.22B 21.86B 273B 21.88B 21.41B 940B
Net income 963M 841M 773M 721M 1.37B 91.65B 1.39B 9.28B 3.61B 45.05B 3.61B 3.54B 155B 1.16B 1.01B 930M 867M 1.64B 110B 1.67B 11.17B 4.34B 54.18B 4.35B 4.25B 187B
Net Debt -405M -354M -325M -303M -575M -38.57B -584M -3.91B -1.52B -18.96B -1.52B -1.49B -65.32B -1.21B -1.06B -973M -907M -1.72B -115B -1.75B -11.68B -4.54B -56.69B -4.55B -4.45B -195B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
03/07/26 €62.20 -0.32% 0
02/07/26 €62.40 +3.31% 320
01/07/26 €60.40 +2.03% 0
30/06/26 €59.20 -2.95% 0
29/06/26 €61.00 +0.66% 36
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
71.25USD
Average target price
85.24USD
Spread / Average Target
+19.64%

Quarterly revenue - Rate of surprise